Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A Systematic Review and Meta‐Analysis

Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A Systematic Review and Meta‐Analysis

ABSTRACT Background and Objectives We aimed to conduct a systematic review and meta‐analysis of high‐throughput sequencing studies to assess changes in microbiome alpha, beta diversity, and composition differences in patients with human papillomavirus (HPV) infection and cervical cancer. Methods The...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Zhang, Yan Ge, Lihe Yao, Qingchun Yan, Jiuju Wei, Yanfei Yin, Bin Liu
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Cancer Reports
Subjects:	cervical cancer high‐throughput sequencing HPV virus meta‐analysis microbiota
Online Access:	https://doi.org/10.1002/cnr2.70246
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaginal microbiota changes of persistent human papillomavirus infection after cervical conization
by: Lingyun Liang, et al.
Published: (2025-04-01)

Human papillomavirus, vaginal microbiota and metagenomics: the interplay between development and progression of cervical cancer
by: Paul Leon-Gomez, et al.
Published: (2025-01-01)

The Prevalence of Human Papillomavirus Genotypes in Women with Precancerous Lesions and Cervical Cancer in Arequipa, Peru
by: Gonzalo Arturo Medina Bueno, et al.
Published: (2025-02-01)

Advances in the Prevention of Cervical Cancer by Anti‐Human Papillomavirus Agents
by: Hangdi Chen, et al.
Published: (2025-04-01)

Knowledge and awareness of cervical cancer and human papillomavirus vaccination among female university students
by: Charles C. Ndubuisi, et al.
Published: (2024-07-01)

ONCOTROPIC PAPILLOMAVIRUS INFECTION AND PROgNOSis FOR PATIENTS WITH CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Influences of vaginal microbiota on human papillomavirus infection and host immune regulation: What we have learned?
by: Yuanyuan Wang, et al.
Published: (2023-01-01)

Cytokines profiles in cervical mucosa in patients with cervical high-risk human papillomavirus infection
by: De-Lai Long, et al.
Published: (2021-05-01)

Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis
by: Yan Peng, et al.
Published: (2025-05-01)

The cervicovaginal microbiota patterns in Moroccan women infected with Human Papillomavirus and/or Chlamydia trachomatis
by: Leila Ferrera, et al.
Published: (2025-09-01)

Prevalence and genotypes’ distribution of human papillomavirus among women in Saudi Arabia: a systematic review and meta-analysis
by: Mohammed S. Aldossary, et al.
Published: (2025-05-01)

Bioinformatics analysis of lncRNA and mRNA differentially expressed in patients with cervical cancer
by: Xiaohua An, et al.
Published: (2025-08-01)

Interconnectedness threat: unveiling the mechanisms behind human papillomavirus-induced cervical cancer
by: Racheal Ahuoyiza Ayeni, et al.
Published: (2025-03-01)

Human Papillomavirus Testing and Disease Recurrence of Cervical Cancer
by: Soheila Aminimoghaddam, et al.
Published: (2023-02-01)

Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening
by: Anna Stasulane, et al.
Published: (2025-06-01)

Prevalence of precancerous cervical lesions and high-risk human papillomavirus types in Yaounde, Cameroon
by: Richard Tagne Simo, et al.
Published: (2021-09-01)

The role of multiple high‐risk human papillomavirus infection on the persistence recurrence of high‐grade cervical lesions after standard treatment: A systematic review and a meta‐analysis
by: Chiara Cassani, et al.
Published: (2024-06-01)

ISSUES OF PATHOGENESIS AND TREATMENT OF UTERINE CERVICAL DISEASES ASSOCIATED WITH PAPILLOMAVIRUS INFECTIONS
by: A. L. Unanyan, et al.
Published: (2016-09-01)

Precise identification of viral–host integration events in HPV-positive cervical cancers by targeted long-read sequencing
by: Preetiparna Parida, et al.
Published: (2025-12-01)

High-risk human papillomavirus: prevalence, association with clinical and morphological characteristics of invasive cervical cancer
by: L. S. Mkrtchian, et al.
Published: (2023-12-01)

Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in cervical samples from Tehran, Iran
by: Mohammad Shabanpour, et al.
Published: (2025-04-01)

Analysis of the Relationship Between Cervical Cancer Progression and the Microbiome
by: Gao YY, et al.
Published: (2025-05-01)

Status and molecular genetic parameters of papillomavirus infection: individual characteristics and associative links with clinical and morphological factors of cervical cancer
by: L. S. Mkrtchian, et al.
Published: (2024-05-01)

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta‐analysis
by: Dina Overgaard Eriksen, et al.
Published: (2022-06-01)

Human Papillomavirus Infection in Partners of Women Attending Cervical Cancer Screening: A Pilot Study on Prevalence, Distribution, and Potential Use of Vaccines
by: Arianna Sucato, et al.
Published: (2025-02-01)

Exploring the role of cervicovaginal microbiota as risk factor for cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis
by: Monique Iheoma Ajah, et al.
Published: (2025-04-01)

Servikal örneklerde human papillomavirus sıklığı ve genotip dağılımı
by: Yücel Fındık, et al.
Published: (2012-01-01)

Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment
by: Nazira Kamzayeva, et al.
Published: (2025-02-01)

Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study
by: Sofie Lindquist, et al.
Published: (2024-09-01)

Expression of human papillomavirus L1 protein and NuMA1 at cervical intraepithelial neoplasia
by: V. A. Ershov, et al.
Published: (2019-11-01)

Vaginal microbiome distinction in women with HPV+, cervical intraepithelial neoplasia, and cervical cancer, a retrospective study
by: Yuanyue Li, et al.
Published: (2025-01-01)

Epidemiologic evaluation of human papillomavirus type competition in unvaccinated women from Xiamen, China
by: Yu Chen, et al.
Published: (2025-04-01)

Clinical factors of development of squamous intraepithelial cervical lesions of high grade in patients with papillomavirus infection
by: T. A. Dimitriadi, et al.
Published: (2020-06-01)

High-risk human papillomavirus genotype distribution and attribution to cervical lesions in a Shanxi Province screening population
by: Ru Shi, et al.
Published: (2025-08-01)

Microbiome and metabolomic changes associated with HPV clearance in women undergoing local excisional treatment for cervical intraepithelial neoplasia
by: Xiaowen Pu, et al.
Published: (2025-06-01)

Human papillomavirus DNA detection in cervical samples from women of reproductive age in Mogadishu, Somalia
by: Bashiru Garba, et al.
Published: (2024-11-01)

Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review
by: Diane M. Harper, et al.
Published: (2025-12-01)

Association between Human papillomavirus infection and abnormal cytopathology of uterine cervix in Baghdad women
by: Nawres A. Tawfeeq, et al.
Published: (2025-04-01)

Evaluation of Cervical Cancer Screening in Japan: Challenges and Future Directions for Negative Intraepithelial Lesion or Malignancy/High-Risk Human Papillomavirus Positive Case Management
by: Yasushi Umezaki, et al.
Published: (2025-05-01)

Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia
by: Baraa Alghalyini, et al.
Published: (2024-12-01)